Vertex Pharmaceuticals Incorporated Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (75)

Latest Posts

About This Stock More About This Stock
Oil Falls Amid Rise In Reserves, China Is Creating A Blockade On Taiwan
Article By: JustMarkets
Thursday, August 4, 2022 7:16 AM EST
Crude oil inventories unexpectedly rose by 4.5 million barrels last week, compared to analysts' forecast of 600,000 barrels. The OPEC+ group said it would raise its oil production target by just 100,000 BPD. Oil prices decreased by 3% on the data.
In this article: COP, AMGN, VRTX, MRNA, BKNG, BABA, PYPL
Read
Best Biotech Stocks To Buy In 2022
Article By: Elliottwave Forecast
Tuesday, March 15, 2022 6:42 AM EST
Biotechnology is the study of living creatures, biological systems, or derivatives to develop or improve healthcare products and therapies. This technology is connected with medical and pharmaceuticals, genomics, and food and chemical manufacturing.
In this article: BMY, JNJ, PFE, NVAX, REGN, AMGN, VRTX, AXSM, GMAB, RLAY
Read
Should We Start Watching Noncyclical Stocks?
Article By: Michele Schneider
Sunday, January 30, 2022 6:00 AM EST
The past week has been very challenging as the market can’t seem to pick a direction. Though short-term momentum has more overhead pressure, even the bears have had difficulty shorting the choppy price action.
In this article: VRTX, DIA, IWM, SPY, LEVI
Read
3 Cathie Wood Stocks To Buy On The Dip
Article By: StockNews
Saturday, December 25, 2021 5:00 PM EST
Institutional investor Cathie Wood gained popularity after her ETFs generated big gains last year. Wood asserted recently that her stocks are poised for long-term gains. Hence, we think investing in Wood’s portfolio stocks might be profitable.
In this article: REGN, TRMB, VRTX Also: SNY, SPY, ARKK
Read
Biotech Playbook 2021 Part 2: Rotation Rally Brings Relief After Fed Pivot
Article By: Rod Raynovich
Wednesday, December 22, 2021 4:52 AM EST
The new aggressive Fed taper combined with a rise in interest rates for 2022 adds a new element of risk to portfolio management. Monetary policy is a headwind for 2022.
In this article: VRTX, IWM, ABBV Also: BMY, SMF, XHE, CYRX, RHHBY, FSMEX, QDEL, REGN, IHI, XBI, XLE, XLF, XLI, CRSP, ARKG, VCYT, PACB, XLV, UNH, PRHSX
Read

Latest Tweets for $VRTX

No tweets yet!

PARTNER HEADLINES